Adam is a life sciences professional, specializing in business development and strategic partnerships for advanced modalities, specifically cell and gene therapies. By leveraging innovation in platform technologies, Adam works with partners to shift the commercial feasibility of therapeutic programs. Adam is currently the VP of Business Development at Cirsium Biosciences, a manufacturing technology company disrupting paradigms in viral vector manufacture to enact a transformation in the accessibility of gene therapies.